As of 2026-09-29, the Relative Valuation of Fate Therapeutics Inc (FATE) is (28.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.35 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -1314.3%.
The range of the Relative Valuation is (28.04) - (29.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.5x - 26.9x | 25.8x |
| Forward P/E multiples | 25.9x - 28.6x | 27.0x |
| Fair Price | (28.04) - (29.03) | (28.54) |
| Upside | -1293.2% - -1335.5% | -1314.3% |
| Date | P/E |
| 2026-09-25 | -2.17 |
| 2026-09-24 | -2.16 |
| 2026-09-23 | -2.25 |
| 2026-09-22 | -2.39 |
| 2026-09-21 | -2.34 |
| 2026-09-18 | -2.34 |
| 2026-09-17 | -2.33 |
| 2026-09-16 | -2.26 |
| 2026-09-15 | -2.17 |
| 2026-09-14 | -2.16 |
| 2026-09-11 | -2.14 |
| 2026-09-10 | -2.16 |
| 2026-09-09 | -2.26 |
| 2026-09-08 | -2.31 |
| 2026-09-04 | -2.29 |
| 2026-09-03 | -2.24 |
| 2026-09-02 | -2.27 |
| 2026-09-01 | -2.25 |
| 2026-08-31 | -2.21 |
| 2026-08-28 | -2.25 |
| 2026-08-27 | -2.35 |
| 2026-08-26 | -2.38 |
| 2026-08-25 | -2.36 |
| 2026-08-24 | -2.26 |
| 2026-08-21 | -2.16 |
| 2026-08-20 | -2.27 |
| 2026-08-19 | -2.45 |
| 2026-08-18 | -2.37 |
| 2026-08-17 | -2.42 |
| 2026-08-14 | -2.38 |
| 2026-08-13 | -2.33 |
| 2026-08-12 | -2.52 |
| 2026-08-11 | -2.53 |
| 2026-08-10 | -2.55 |
| 2026-08-07 | -2.59 |
| 2026-08-06 | -2.30 |
| 2026-08-05 | -2.41 |
| 2026-08-04 | -2.38 |
| 2026-08-03 | -2.31 |
| 2026-07-31 | -2.27 |
| 2026-07-30 | -2.32 |
| 2026-07-29 | -2.18 |
| 2026-07-28 | -2.15 |
| 2026-07-27 | -2.25 |
| 2026-07-24 | -2.23 |
| 2026-07-23 | -2.33 |
| 2026-07-22 | -2.39 |
| 2026-07-21 | -2.62 |
| 2026-07-20 | -2.59 |
| 2026-07-17 | -2.57 |